We serve Chemical Name:4-Bromo-4′-tert-butylbiphenyl CAS:162258-89-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-Bromo-4′-tert-butylbiphenyl
CAS.NO:162258-89-1
Synonyms:4-Bromo-4′-tert-butylbiphenyl;1-bromo-4-(4-tert-butylphenyl)benzene
Molecular Formula:C16H17Br
Molecular Weight:289.21000
HS Code:2903999090
Physical and Chemical Properties:
Melting point:143ºC
Boiling point:152ºC/2mm
Density:1.217g/cm3
Index of Refraction:1.561
PSA:
Exact Mass:288.05100
LogP:5.41360
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-Bromo-4′-tert-butylbiphenyl chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-bromo-4-(4-tert-butylphenyl)benzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Bromo-4′-tert-butylbiphenyl Use and application,1-bromo-4-(4-tert-butylphenyl)benzene technical grade,usp/ep/jp grade.
Related News: On the other hand, the company has many new products in recent years, including Duqiao Base, Yancheng United Chemical and Dezhou United Chemical. These new products are mostly customized products with strong profitability, which has improved the gross profit margin of the industrial business. 4-Bromo-4′-tert-butylbiphenyl manufacturer Health Canada said it was planning an onsite inspection this summer and that it would not accept any product or ingredients made at the plant until the inspection was complete. 4-Bromo-4′-tert-butylbiphenyl supplier According to statistics, in the ten years from 2008 to 2017, a total of 13 China Class 1 small-molecule chemical drugs were independently researched and developed by domestic enterprises in China and approved by the CFDA; in 2018, there were 10 varieties of domestic Class 1 new drugs. Approved for listing in China. 4-Bromo-4′-tert-butylbiphenyl vendor Health Canada said it was planning an onsite inspection this summer and that it would not accept any product or ingredients made at the plant until the inspection was complete. 4-Bromo-4′-tert-butylbiphenyl factory A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018.
